United States Anticoagulant Drug Market Report 2016

October 2016 | 116 pages | ID: U89AFD88ACFEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Anticoagulant Drug

Revenue, means the sales value of Anticoagulant Drug

This report studies sales (consumption) of Anticoagulant Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Bayer AG
• Pfizer Inc
• Merck
• Sanofi
• Abbott Laboratories
• Johnson & Johnson
• Armetheon Inc
• Microbix Biosystems Inc
• Biovascular Inc
• Baxter International
• Astrazeneca
• Genentech
• Boehringer Ingelheim Gmbh
• Bristol-Myers Squibb CO
• CSL Behring
• ELI LILLY
• Emisphere Technologies
• Sun Pharmaceuticals
• Shire Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Anticoagulant Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Anticoagulant Drug Market Report 2016

1 ANTICOAGULANT DRUG OVERVIEW

1.1 Product Overview and Scope of Anticoagulant Drug
1.2 Classification of Anticoagulant Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Anticoagulant Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Anticoagulant Drug (2011-2021)
  1.4.1 United States Anticoagulant Drug Sales and Growth Rate (2011-2021)
  1.4.2 United States Anticoagulant Drug Revenue and Growth Rate (2011-2021)

2 UNITED STATES ANTICOAGULANT DRUG COMPETITION BY MANUFACTURERS

2.1 United States Anticoagulant Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Anticoagulant Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Anticoagulant Drug Average Price by Manufactures (2015 and 2016)
2.4 Anticoagulant Drug Market Competitive Situation and Trends
  2.4.1 Anticoagulant Drug Market Concentration Rate
  2.4.2 Anticoagulant Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ANTICOAGULANT DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Anticoagulant Drug Sales and Market Share by Type (2011-2016)
3.2 United States Anticoagulant Drug Revenue and Market Share by Type (2011-2016)
3.3 United States Anticoagulant Drug Price by Type (2011-2016)
3.4 United States Anticoagulant Drug Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ANTICOAGULANT DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Anticoagulant Drug Sales and Market Share by Application (2011-2016)
4.2 United States Anticoagulant Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ANTICOAGULANT DRUG MANUFACTURERS PROFILES/ANALYSIS

5.1 Bayer AG
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Anticoagulant Drug Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Bayer AG Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Pfizer Inc
  5.2.2 Anticoagulant Drug Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Pfizer Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Merck
  5.3.2 Anticoagulant Drug Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Merck Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Sanofi
  5.4.2 Anticoagulant Drug Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Sanofi Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Abbott Laboratories
  5.5.2 Anticoagulant Drug Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Abbott Laboratories Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Johnson & Johnson
  5.6.2 Anticoagulant Drug Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Johnson & Johnson Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Armetheon Inc
  5.7.2 Anticoagulant Drug Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Armetheon Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Microbix Biosystems Inc
  5.8.2 Anticoagulant Drug Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Microbix Biosystems Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Biovascular Inc
  5.9.2 Anticoagulant Drug Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Biovascular Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Baxter International
  5.10.2 Anticoagulant Drug Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Baxter International Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Astrazeneca
5.12 Genentech
5.13 Boehringer Ingelheim Gmbh
5.14 Bristol-Myers Squibb CO
5.15 CSL Behring
5.16 ELI LILLY
5.17 Emisphere Technologies
5.18 Sun Pharmaceuticals
5.19 Shire Pharmaceuticals

6 ANTICOAGULANT DRUG MANUFACTURING COST ANALYSIS

6.1 Anticoagulant Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Anticoagulant Drug

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Anticoagulant Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Anticoagulant Drug Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ANTICOAGULANT DRUG MARKET FORECAST (2016-2021)

10.1 United States Anticoagulant Drug Sales, Revenue Forecast (2016-2021)
10.2 United States Anticoagulant Drug Sales Forecast by Type (2016-2021)
10.3 United States Anticoagulant Drug Sales Forecast by Application (2016-2021)
10.4 Anticoagulant Drug Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anticoagulant Drug
Table Classification of Anticoagulant Drug
Figure United States Sales Market Share of Anticoagulant Drug by Type in 2015
Table Application of Anticoagulant Drug
Figure United States Sales Market Share of Anticoagulant Drug by Application in 2015
Figure United States Anticoagulant Drug Sales and Growth Rate (2011-2021)
Figure United States Anticoagulant Drug Revenue and Growth Rate (2011-2021)
Table United States Anticoagulant Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Anticoagulant Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Anticoagulant Drug Sales Share by Manufacturers
Figure 2016 Anticoagulant Drug Sales Share by Manufacturers
Table United States Anticoagulant Drug Revenue by Manufacturers (2015 and 2016)
Table United States Anticoagulant Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Anticoagulant Drug Revenue Share by Manufacturers
Table 2016 United States Anticoagulant Drug Revenue Share by Manufacturers
Table United States Market Anticoagulant Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Anticoagulant Drug Average Price of Key Manufacturers in 2015
Figure Anticoagulant Drug Market Share of Top 3 Manufacturers
Figure Anticoagulant Drug Market Share of Top 5 Manufacturers
Table United States Anticoagulant Drug Sales by Type (2011-2016)
Table United States Anticoagulant Drug Sales Share by Type (2011-2016)
Figure United States Anticoagulant Drug Sales Market Share by Type in 2015
Table United States Anticoagulant Drug Revenue and Market Share by Type (2011-2016)
Table United States Anticoagulant Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Anticoagulant Drug by Type (2011-2016)
Table United States Anticoagulant Drug Price by Type (2011-2016)
Figure United States Anticoagulant Drug Sales Growth Rate by Type (2011-2016)
Table United States Anticoagulant Drug Sales by Application (2011-2016)
Table United States Anticoagulant Drug Sales Market Share by Application (2011-2016)
Figure United States Anticoagulant Drug Sales Market Share by Application in 2015
Table United States Anticoagulant Drug Sales Growth Rate by Application (2011-2016)
Figure United States Anticoagulant Drug Sales Growth Rate by Application (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer AG Anticoagulant Drug Sales Market Share (2011-2016)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc Anticoagulant Drug Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Anticoagulant Drug Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Anticoagulant Drug Sales Market Share (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories Anticoagulant Drug Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Anticoagulant Drug Sales Market Share (2011-2016)
Table Armetheon Inc Basic Information List
Table Armetheon Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Armetheon Inc Anticoagulant Drug Sales Market Share (2011-2016)
Table Microbix Biosystems Inc Basic Information List
Table Microbix Biosystems Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Microbix Biosystems Inc Anticoagulant Drug Sales Market Share (2011-2016)
Table Biovascular Inc Basic Information List
Table Biovascular Inc Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biovascular Inc Anticoagulant Drug Sales Market Share (2011-2016)
Table Baxter International Basic Information List
Table Baxter International Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxter International Anticoagulant Drug Sales Market Share (2011-2016)
Table Astrazeneca Basic Information List
Table Astrazeneca Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astrazeneca Anticoagulant Drug Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Anticoagulant Drug Sales Market Share (2011-2016)
Table Boehringer Ingelheim Gmbh Basic Information List
Table Boehringer Ingelheim Gmbh Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Gmbh Anticoagulant Drug Sales Market Share (2011-2016)
Table Bristol-Myers Squibb CO Basic Information List
Table Bristol-Myers Squibb CO Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb CO Anticoagulant Drug Sales Market Share (2011-2016)
Table CSL Behring Basic Information List
Table CSL Behring Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Behring Anticoagulant Drug Sales Market Share (2011-2016)
Table ELI LILLY Basic Information List
Table ELI LILLY Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table ELI LILLY Anticoagulant Drug Sales Market Share (2011-2016)
Table Emisphere Technologies Basic Information List
Table Emisphere Technologies Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Emisphere Technologies Anticoagulant Drug Sales Market Share (2011-2016)
Table Sun Pharmaceuticals Basic Information List
Table Sun Pharmaceuticals Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceuticals Anticoagulant Drug Sales Market Share (2011-2016)
Table Shire Pharmaceuticals Basic Information List
Table Shire Pharmaceuticals Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shire Pharmaceuticals Anticoagulant Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anticoagulant Drug
Figure Manufacturing Process Analysis of Anticoagulant Drug
Figure Anticoagulant Drug Industrial Chain Analysis
Table Raw Materials Sources of Anticoagulant Drug Major Manufacturers in 2015
Table Major Buyers of Anticoagulant Drug
Table Distributors/Traders List
Figure United States Anticoagulant Drug Production and Growth Rate Forecast (2016-2021)
Figure United States Anticoagulant Drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Anticoagulant Drug Production Forecast by Type (2016-2021)
Table United States Anticoagulant Drug Consumption Forecast by Application (2016-2021)